Product Details
Synonyms
CD19, B4, CVID3, MGC12802
Source
Biotinylated Human CD19 (20-278) Superstable Mutant Protein, His,Avitag™, premium grade (CD9-H82Ec) is expressed from human 293 cells (HEK293). It contains AA Pro 20 - Pro 278 (Accession # P15391-1).
Predicted N-terminus: Pro 20
It is produced under our rigorous quality control system that incorporates a comprehensive set of tests including sterility and endotoxin tests. Product performance is carefully validated and tested for compatibility for cell culture use or any other applications in the early preclinical stage. When ready to transition into later clinical phases, we also offer a custom GMP protein service that tailors to your needs. We will work with you to customize and develop a GMP-grade product in accordance with your requests that also meets the requirements for raw and ancillary materials use in cell manufacturing of cell-based therapies.
Request for sequenceMolecular Characterization

Other Tags and Version Biotin & Other Labeled Version
This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag™).
The protein has a calculated MW of 32.0 kDa. The protein migrates as 43-58 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
Within the expressed region, several mutations were introduced to optimize the protein expression and stability.
Labeling
Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.
Protein Ratio
Passed as determined by the HABA assay / binding ELISA.
Application
Plate immobilization or bead conjugation for cell sorting and activation.
Endotoxin
Less than 0.01 EU per μg by the LAL method / rFC method.
Sterility
Negative
Mycoplasma
Negative
Purity
>95% as determined by SDS-PAGE.
>95% as determined by SEC-MALS.
Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
ACRO Quality Management System
Customers Also Viewed
Performance Data
SDS-PAGE

Biotinylated Human CD19 (20-278) Superstable Mutant Protein, His,Avitag™, premium grade on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).
SEC-MALS

The purity of Biotinylated Human CD19 (20-278) Superstable Mutant Protein, His,Avitag™, premium grade (Cat. No. CD9-H82Ec) is more than 95% and the molecular weight of this protein is around 35-55 kDa verified by SEC-MALS.
Report
Bioactivity-FACS

2e5 of anti-CD19 CAR-293 cells were stained with 100 μL of 1 μg/mL of Biotinylated Human CD19 (20-278) Superstable Mutant Protein, His,Avitag™, premium grade (Cat. No. CD9-H82Ec) and negative control protein respectively, washed and then followed by PE-SA and analyzed with FACS (QC tested).
Protocol
Bioactivity-ELISA

Immobilized Biotinylated Human CD19 (20-278) Superstable Mutant Protein, His,Avitag™, premium grade (Cat. No. CD9-H82Ec) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Monoclonal Anti-Human CD19 Antibody, Mouse IgG2a with a linear range of 0.02-1 ng/mL (QC tested).
Protocol
Immobilized Biotinylated Human CD19 (20-278) Superstable Mutant Protein, His,Avitag™, premium grade (Cat. No. CD9-H82Ec) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Monoclonal Anti-Human CD19 Antibody, Human IgG1 with a linear range of 0.02-1 ng/mL (Routinely tested).
Protocol
Bioactivity-SPR

Biotinylated Human CD19 (20-278) Superstable Mutant Protein, His,Avitag™, premium grade (Cat. No. CD9-H82Ec) immobilized on SA Chip can bind Monoclonal Anti-Human CD19 Antibody, Mouse IgG2a with an affinity constant of 65.2 pM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Protocol
Customer Reviews Writing Reviews

Background
Recent Advances
- English Name:
B-lymphocyte antigen CD19
- Category:
- Approved Drugs:
14 Details
- Drugs in Clinical Trials:
435 Details
- Highest Development Stage:
Approved



















